Management tracks: Gilead, bluebird, Apollomics

Gilead Sciences Inc. (NASDAQ:GILD) said Robin Washington will retire as EVP and CFO, effective March 1, 2020. Washington, who joined Gilead in 2008, will continue in her role while the company identifies a successor.

Gene therapy company bluebird bio Inc. (NASDAQ:BLUE) promoted Joanne Smith-Farrell to CBO from SVP of corporate development and strategy. She will also continue to serve as oncology franchise leader. ...